Advertisement

Quality Measures for Parkinson’s Disease Care

Quality measures have been developed for many different frameworks of medical care to address structures, processes, and/or outcomes. They also address important components of healthcare quality, including patient safety, timeliness, effectiveness, efficiency, equity, and patient-centeredness. Performance metrics and quality measures are increasingly becoming important for measuring progress and determining reimbursement for physicians and other providers. “When these measures are utilized in their entirety, they provide a framework for uniform quality and assessment of the many facetsand presentations of PD.” The American Academy of Neurology (AAN) established its own measures to improve the quality of treatment provided for Parkinson’s disease (PD) and to better understand how to improve quality of life in this patient group. In the November 30, 2010 issue of Neurology, my colleagues and I published a set of 10 quality measures for the care of patients with PD that were endorsed by the AAN. These measures are the result of a collaboration of a 28-person expert panel. Each measure identifies the patient population eligible for the measure—all patients with a diagnosis of PD—and identifies the temporal application. Once clinicians determine whether patients are eligible, then the measure states how it’s fulfilled. Clinicians managing patients with PD can then implement strategies to identify appropriate candidates and determine how to conduct assessments. Summarizing Quality Measures for Parkinson’s Disease Six of the measures address the assessment of PD symptoms, three cover the current diagnosis and treatment, and one covers patient safety and counseling on preventable complications. The first quality measure for PD is that all patients with the disease have their diagnosis and current medications reviewed at least annually, including a review...
[ HIDE/SHOW ]